Suppr超能文献

糖尿病合并复杂性尿路感染

Complicated urinary tract infections with diabetes mellitus.

作者信息

Kamei Jun, Yamamoto Shingo

机构信息

Department of Urology, Jichi Medical University, Tochigi, Japan.

Department of Urology, Hyogo College of Medicine, Hyogo, Japan.

出版信息

J Infect Chemother. 2021 Aug;27(8):1131-1136. doi: 10.1016/j.jiac.2021.05.012. Epub 2021 May 20.

Abstract

Patients with diabetes mellitus (DM) sometimes exhibited impaired immune function and aggravated infectious diseases. Urinary tract infection (UTI) is one of the major complications of DM. A systematic literature search was performed in PubMed and Cochrane Library using the following keywords: diabetes mellitus, urinary tract infection, asymptomatic bacteriuria, emphysematous pyelonephritis, emphysematous cystitis, renal papillary necrosis, and sodium-glucose co-transporter 2 (SGLT2) inhibitors. The treatment of UTI in DM patients is not different from that in non-DM patients, and asymptomatic bacteriuria should not be screened or treated. Emphysematous pyelonephritis is a life-threatening renal infection with gas in the renal parenchyma or perirenal space, and 95% of affected patients had DM. Abdominal computed tomography is useful for diagnosis and determining treatment strategies. Medical management and percutaneous drainage are standard initial treatment, and subsequent nephrectomy for non-responders is considered. Nephrectomy, as an initial treatment, should be limited to a selected group of patients with severe conditions. In contrast, antibiotics, glycemic control, and bladder drainage are adequate treatment for most cases of emphysematous cystitis. SGLT2 inhibitors significantly increased the incidence of genital tract infection, but not that of UTI, pyelonephritis, or urosepsis. Here, we present cumulative evidence about etiology and management for complicated UTI with DM, but there was little information about racial differences and further evidence focusing on Asian population will be needed.

摘要

糖尿病患者有时会出现免疫功能受损和感染性疾病加重的情况。尿路感染(UTI)是糖尿病的主要并发症之一。我们在PubMed和Cochrane图书馆进行了系统的文献检索,使用了以下关键词:糖尿病、尿路感染、无症状菌尿、气肿性肾盂肾炎、气肿性膀胱炎、肾乳头坏死和钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂。糖尿病患者尿路感染的治疗与非糖尿病患者并无不同,无症状菌尿不应进行筛查或治疗。气肿性肾盂肾炎是一种危及生命的肾脏感染,肾实质或肾周间隙有气体,95%的患者患有糖尿病。腹部计算机断层扫描有助于诊断和确定治疗策略。药物治疗和经皮引流是标准的初始治疗方法,对于无反应者可考虑后续肾切除术。肾切除术作为初始治疗,应限于选定的病情严重的患者群体。相比之下,抗生素、血糖控制和膀胱引流对大多数气肿性膀胱炎病例来说是足够的治疗方法。SGLT2抑制剂显著增加了生殖道感染的发生率,但未增加尿路感染、肾盂肾炎或脓毒症的发生率。在此,我们提供了关于糖尿病合并复杂性尿路感染的病因和管理的累积证据,但关于种族差异的信息很少,还需要更多关注亚洲人群的进一步证据。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验